American Lung Association Applauds Volunteers and Advocates for Focusing FDA on Lung Cancer and Interstitial Lung Disease ...
Washington, D.C. (April 11, 2013)— Harold P. Wimmer, National President and CEO of the American Lung Association, issued the following statement in response to the U.S. Food and Drug Administration’s (FDA) decision to include lung cancer and interstitial …